Product Information
BUPROPION HCL SR 150 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.0824 per EA under NDC 43547028950. Its NADAC has been published 563 times since Nov 11, 2015.
FDA first approved this application on May 26, 2015. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547028950
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BUPROPION HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202304FDA Approved
5/26/2015
TE Code
AB1
On Market Since
11/1/2014
Pharmacological Classes
Price Statistics
The NADAC for BUPROPION HCL SR 150 MG TABLET has been published 563 times since Nov 11, 2015, and over the history we have for it it has declined 51.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0824 per EA |
|---|---|
| All-time high | $0.1694 (Nov 11, 2015) |
| All-time low | $0.0709 (May 22, 2024) |
| 52-week high | $0.0852 |
| 52-week low | $0.0805 |
| Median price | $0.1143 |
| Average price | $0.1120 |
| Largest weekly change | +20.0% (Jun 19, 2024) |
| Weeks tracked | 563 |
| Tracking since | Nov 11, 2015 |
Generic Alternatives
The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUPROPION HCL SR 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL SR 150 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.0824 per EA (NDC 43547028950), effective Aug 19, 2026.
How has the price of BUPROPION HCL SR 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUPROPION HCL SR 150 MG TABLET has declined 51.4%. It has been tracked across 563 weekly CMS publications since Nov 11, 2015.
What are the highest and lowest recorded NADAC prices for BUPROPION HCL SR 150 MG TABLET?
Since Nov 11, 2015, the NADAC for BUPROPION HCL SR 150 MG TABLET has ranged from a low of $0.0709 (May 22, 2024) to a high of $0.1694 (Nov 11, 2015), with a median of $0.1143 per EA.
Are there cheaper alternatives to BUPROPION HCL SR 150 MG TABLET?
Yes. 14 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUPROPION HCL XL 150 MG TABLET, is $0.0779 per EA — about 5% below BUPROPION HCL SR 150 MG TABLET.
Who manufactures BUPROPION HCL SR 150 MG TABLET?
BUPROPION HCL SR 150 MG TABLET (NDC 43547028950) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.